Company Overview and News

 
Former AG is Versatile's new chairman

2018-10-02 theedgemarkets
KUALA LUMPUR: Former attorney-general (AG) Tan Sri Abdul Gani Patail has been redesignated from his position of non-executive director to executive chairman of Versatile Creative Bhd effective immediately.
4995 BSMAF 1818

 
Former AG is Versatile Creative's new chairman

2018-10-01 theedgemarkets
KUALA LUMPUR (Oct 1): Former Attorney-General Tan Sri Abdul Gani Patail has been re-designated from his position of non-executive director to executive chairman of Versatile Creative Bhd effective immediately.
4995 BSMAF 1818

 
KLCI to trade range bound, hover around 1,800-level

2018-09-17 theedgemarkets
KUALA LUMPUR (Sept 18): The FBM KLCI is expected trade range bound today and hover around the 1,800-point level today, given the positive domestic sentiment after Morgan Stanley last week upgraded Malaysia stocks to equal weight
GMALF 7006 9598 GMALY 4995 4715 7208 MS

 
Tropicana, Latitude Tree, Versatile Creative, Vertice, Euro Holdings, Genting Malaysia, Gamuda and Pintaras Jaya

2018-09-14 theedgemarkets
KUALA LUMPUR (Sept 14): Based on corporate announcements and news flow today, companies that may be in focus on Tuesday (Sept 18) may include the following: Tropicana Corp Bhd, Latitude Tree Holdings Bhd, Versatile Creative Bhd, Vertice Bhd, Euro Holdings Bhd, Genting Malaysia Bhd, Gamuda Bhd and Pintaras Jaya Bhd.
GMALY 4995 4715 GMALF 7208 7006 BSMAF 9598 1818

 
Versatile Creative to resume trading after releasing annual report

2018-09-14 theedgemarkets
KUALA LUMPUR (Sept 14): Shares of Versatile Creative Bhd are set to resume trading next Tuesday (Sept 18), after the group submitted its annual report to Bursa Malaysia today.
4995 BSMAF 1818

 
New blood at Versatile Creative

2018-09-03 theedgemarkets
KUALA LUMPUR: Versatile Creative Bhd’s largest shareholder has succeeded in getting a new set of directors appointed, but problems at the loss-making plastic packaging manufacturer remain for now.
4995 FLLZ BSMAF 1818

 
Versatile Creative shareholders approve appointment of 7 new directors at EGM

2018-08-30 theedgemarkets
KUALA LUMPUR (Aug 30): Shareholders of plastic packaging manufacturer Versatile Creative Bhd approved seven resolutions for the appointment of seven new directors at its extraordinary general meeting that was held today (EGM).
4995 BSMAF 1818

 
Versatile Creative's major shareholder NSK files suit against appointment of 2 directors

2018-08-29 theedgemarkets
KUALA LUMPUR (Aug 29): As shareholders of Versatile Creative Bhd convene an extraordinary general meeting (EGM) here tomorrow called by its largest shareholder NSK Trading Sdn Bhd to decide on the appointment of seven directors to its board, NSK had also earlier filed a suit against the appointment of two others to the board.
4995 BSMAF 1818

 
Trading ideas: Versatile, AMMB, Sunway, Paramount, Ranhill, MCT

2018-08-23 thestar.com.my
KUALA LUMPUR: Versatile Creative Bhd , AMMB Holdings Bhd , Sunway Bhd , Paramount Corp Bhd, Ranhill Holdings Bhd and MCT Bhd are among the stocks to watch on Thursday, according to JF Apex Research.
4995 1015 AMMHF 5272

 
Packaging firm Versatile axes MD and CFO over missing RM2.3mil

2018-08-22 thestar.com.my
PETALING JAYA: Packaging firm Versatile Creative Bhd has sacked managing director (MD) Datuk Wong Kong Choong @ Leong Kong Choong and chief financial officer (CFO) Tan Quok Eow over a missing sum of RM2.3mil.
4995 BSMAF 1818

 
Sime Darby Plantation, PetChem, E&O, MCT, Taliworks, Ranhill, Versatile Creative, AMMB, Sunway and Paramount

2018-08-21 theedgemarkets
KUALA LUMPUR (Aug 20): Based on corporate announcements and news flow today, companies that will be in focus on Thursday (Aug 23) may include: Sime Darby Plantation Bhd, Petronas Chemicals Group Bhd, Eastern & Oriental Bhd, MCT Bhd, Taliworks Corp, Ranhill Holdings Bhd, Versatile Creative Bhd, AMMB Holdings Bhd, Sunway Bhd and Paramount Corp Bhd.
4995 1015 5183 PECGF AMMHF 5272

 
Versatile Creative MD, CFO fired; ex-Commissioner of Police joins board

2018-08-21 theedgemarkets
KUALA LUMPUR (Aug 21): Versatile Creative Bhd said today it has fired its managing director (MD) Datuk Wong Kong Choong @ Leong Kong Choong and group chief financial officer (CFO) Tan Quok Eow from their employment with immediate effect for failing to satisfactorily answer the allegations made against them in the show-cause letters that were issued to them earlier.
4995 BSMAF 1818

 
Versatile sacks MD, group financial officer over missing funds

2018-08-21 thestar.com.my
KUALA LUMPUR: Packaging firm Versatile Creative Bhd has sacked managing director Datuk Wong Kong Choong @ Leong Kong Choong and group financial officer Tan Quok Eow over the missing RM2.3mil.
4995 BSMAF 1818

 
KLCI seen rising amid global relief rally, support at 1,773

2018-08-15 theedgemarkets
KUALA LUMPUR (Aug 15): The FBM KLCI is seen rising amid some overnight relief rally at most global markets, immediate support at 1,773.
7158 DKSHY 6912 KLKBY 2445 4995 5225 6238 4405 1899 Q0F IHHHF 5908 DKSHF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...